---
title: "This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296102902.md"
description: "Goldman Sachs analyst James Schneider initiated coverage on Onto Innovation Inc (NYSE:ONTO) with a Buy rating and a $400 price target, noting the stock closed at $331.71. Other analysts also initiated coverage on Columbia Financial, Target Hospitality, Dave Inc, and Pulse Biosciences with positive ratings and specific price targets."
datetime: "2026-08-17T11:56:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296102902.md)
  - [en](https://longbridge.com/en/news/296102902.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296102902.md)
generator: "portal-rs"
---

# This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Goldman Sachs analyst James Schneider initiated coverage on **Onto Innovation Inc** (NYSE:ONTO) with a Buy rating and announced a price target of $400. Onto Innovation closed at $331.71 on Friday. See how other analysts view this stock.
-   Keefe, Bruyette & Woods analyst Damon Delmonte initiated coverage on **Columbia Financial Inc** (NASDAQ:CLBK) with an Outperform rating and announced a price target of $14.5. Columbia Financial shares closed at $11.79 on Friday. See how other analysts view this stock.
-   Morgan Stanley analyst Angel Castillo initiated coverage on **Target Hospitality Corp** (NASDAQ:TH) with an Overweight rating and announced a price target of $22. Target Hospitality closed at $17.44 on Friday. See how other analysts view this stock.
-   Piper Sandler analyst Patrick Moley initiated coverage on **Dave Inc** (NASDAQ:DAVE) with an Overweight rating and announced a price target of $390. Dave shares closed at $334.57 on Friday. See how other analysts view this stock.
-   Needham analyst Mike Matson initiated coverage on **Pulse Biosciences Inc** (NASDAQ:PLSE) with a Buy rating and announced a price target of $58. Pulse Biosciences closed at $44.54 on Friday. See how other analysts view this stock.

Considering buying ONTO stock? Here’s what analysts think:

Photo via Shutterstock

### Related Stocks

- [ONTO.US](https://longbridge.com/en/quote/ONTO.US.md)
- [DAVE.US](https://longbridge.com/en/quote/DAVE.US.md)
- [PLSE.US](https://longbridge.com/en/quote/PLSE.US.md)
- [DAVEW.US](https://longbridge.com/en/quote/DAVEW.US.md)
- [TH.US](https://longbridge.com/en/quote/TH.US.md)
- [CLBK.US](https://longbridge.com/en/quote/CLBK.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Onto Innovation (ONTO) Stock Stays Reasonable Despite Its 243% Five Year Run](https://longbridge.com/en/news/297677830.md)
- [Jefferies Financial Group Inc. Takes Position in Onto Innovation Inc. $ONTO](https://longbridge.com/en/news/297399253.md)
- [Onto Innovation director Susan D. Lynch sells 1,000 shares valued at $302,300](https://longbridge.com/en/news/297021581.md)
- [Persistent Asset Partners Ltd Takes $2.25 Million Position in Onto Innovation Inc. $ONTO](https://longbridge.com/en/news/296092444.md)
- [Target Hospitality forecasts 2026 adjusted EBITDA of $105 million-$115 million](https://longbridge.com/en/news/297648373.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**